Terminology Service < Semantic Lookup Platform

All terms in CHEBI

Label	Id	Description
N-[(4R,7R,8S)-5-[(3-fluorophenyl)methyl]-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide	CHEBI_111858
N-[(5R,6S,9R)-5-methoxy-8-[(4-methoxyphenyl)methyl]-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-1,3-benzothiazole-2-carboxamide	CHEBI_111859
13'-hydroxy-alpha-tocotrienol	CHEBI_145208
2,8-dihydroxyquinoline-beta-D-glucuronide	CHEBI_145209
myricetin 3-O-[(6-O-caffeoyl-beta-D-glucosyl)-(1->2)-alpha-L-rhamnoside]	CHEBI_145204	[A glycosyloxyflavone that is myricetin 3-O-[beta-D-glucosyl-(1->2)-alpha-L-rhamnoside] in which the hydroxy group at position 6 of the glucosyl group has been acylated by a caffeoyl [(1E)-1-(3,4-dihydroxyphenyl)-3-oxoprop-1-en-3-yl] group.]
myricetin 3-O-[(6-O-caffeoyl-beta-D-glucosyl)-(1->2)-alpha-L-rhamnoside](1-)	CHEBI_144428	[A flavonoid oxoanion resulting from the deprotonation of the hydroxy group at position 7 of myricetin 3-O-[(6-O-caffeoyl-beta-D-glucosyl)-(1->2)-alpha-L-rhamnoside]. The major species at pH 7.3.]
myricetin 3-O-[beta-D-glucosyl-(1->2)-alpha-L-rhamnoside]	CHEBI_145201	[A glycosyloxyflavone that is myricetin in which the hydroxy group at position 3 has been converted to the corresponding beta-D-glucosyl-(1->2)-alpha-L-rhamnoside.]
(R)-3-hydroxyoctadecanoic acid	CHEBI_145205
3-hydroxyoctadecanoic acid	CHEBI_50578
(S)-3-hydroxyoctadecanoic acid	CHEBI_50579	[A 3-hydroxyoctadecanoic acid in which the chiral centre has S configuration.]
12-hydroxynevirapine	CHEBI_145206	[A dipyridodiazepine that is nevirapine in which one of the hydrogens of the methyl group has been substituted by a hydroxy group. It is a metabolite of the anti-HIV drug, nevirapine.]
dipyridodiazepine	CHEBI_63667	[An organic heterotricyclic compound whose skeleton consists of a diazepine ring which is fused to two pyridine rings.]
nevirapine	CHEBI_63613	[A dipyridodiazepine that is 5,11-dihydro-6H-dipyrido[3,2-b:2',3'-e][1,4]diazepine which is substituted by methyl, oxo, and cyclopropyl groups at positions 4, 6, and 11, respectively. A non-nucleoside reverse transcriptase inhibitor with activity against HIV-1, it is used in combination with other antiretrovirals for the treatment of HIV infection.]
13'-carboxy-alpha-tocopherol	CHEBI_145207
tocopherol	CHEBI_27013	[A collective name for a group of closely related lipids that contain a chroman-6-ol nucleus substituted at position 2 by a methyl group and by a saturated hydrocarbon chain consisting of three isoprenoid units. They are designated as alpha-, beta-, gamma-, and delta-tocopherol depending on the number and position of additional methyl substituents on the aromatic ring. Tocopherols occur in vegetable oils and vegetable oil products, almost exclusively with R,R,R configuration. Tocotrienols differ from tocopherols only in having three double bonds in the hydrocarbon chain.]
11-dehydroxy-mogroside IIE	CHEBI_145200
myricetin 3-O-[beta-D-glucosyl-(1->2)-alpha-L-rhamnoside](1-)	CHEBI_144429	[A flavonoid oxoanion resulting from the deprotonation of the hydroxy group at position 7 of myricetin 3-O-[beta-D-glucosyl-(1->2)-alpha-L-rhamnoside]. The major species at pH 7.3.]
L-guloside	CHEBI_145203	[Any guloside in which the glycoside group is derived from L-gulose.]
N-[(4R,7S,8S)-5-[(3-fluorophenyl)methyl]-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide	CHEBI_111850
2-methoxy-N-[(5S,6R,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzamide	CHEBI_111851